Diagnosis and Therapeutic Center, Hôtel Dieu Hospital, Paris, France.
Preventive Cardiology Dept, Institute of Cardiology Named After Levon Hovhannisyan, Yerevan, Armenia.
Vasc Health Risk Manag. 2022 Mar 31;18:191-200. doi: 10.2147/VHRM.S350006. eCollection 2022.
As recommended by various authorities and scientific societies, electronic devices for blood pressure (BP) measurements must undergo independent clinical validations for accuracy assessment.
To assess the accuracy of the Withings BPM Connect device in the general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization "AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018)".
The Withings BPM Connect device measures BP at the brachial level using the oscillometric method. According to this protocol using the same-arm sequential BP measurement method, subjects (n ≥ 85) fulfilling the age, gender, BP and cuff distribution criteria must be included. Two criteria are used for the analysis: Criterion 1: differences between observers' mercury sphygmomanometer reference measurements and test device BP values (test versus reference) and their standard deviation (SD) must be ≤5 ± 8 mmHg for both systolic (SBP) and diastolic BP (DBP). Criterion 2: the SD of the mean BP differences between the test device and reference BP per subject must be ≤6.91/6.62 mmHg for SBP/DBP.
Ninety-two subjects were selected, 85 of whom were included. For validation criterion 1, the mean difference ± SD between the reference and device BP values was 0.6 ± 5.3 mmHg for SBP and 2.1 ± 4.3 mmHg for DBP. For criterion 2, the SD of the mean BP differences between the test device and reference BP per subject was 4.2/3.6 mmHg (SBP/DBP). These results fulfilled the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) protocol requirements.
The Withings BPM Connect oscillometric device for home BP measurement fulfilled all of the accuracy requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) in general population and consequently can be recommended for home BP measurements.
根据各种权威机构和科学协会的建议,电子血压(BP)测量设备必须经过独立的临床验证以评估准确性。
根据医疗器械促进协会/欧洲高血压学会/国际标准化组织“医疗器械促进会/欧洲高血压学会/国际标准化组织通用标准(ISO 81060-2:2018)”,评估 Withings BPM Connect 设备在普通人群中的准确性。
Withings BPM Connect 设备使用示波法在肱动脉水平测量血压。根据该协议,使用相同手臂顺序血压测量方法,必须纳入符合年龄、性别、血压和袖带分布标准的受试者(n≥85)。分析使用两个标准:标准 1:观察者汞柱血压计参考测量值与测试设备血压值(测试与参考)及其标准差(SD)之间的差异必须≤5±8mmHg,适用于收缩压(SBP)和舒张压(DBP)。标准 2:每个受试者测试设备和参考血压之间平均血压差异的 SD 必须≤6.91/6.62mmHg,适用于 SBP/DBP。
选择了 92 名受试者,其中 85 名被纳入。对于验证标准 1,参考和设备血压值之间的平均差值±SD 为 SBP 为 0.6±5.3mmHg,DBP 为 2.1±4.3mmHg。对于标准 2,每个受试者测试设备和参考血压之间平均血压差异的 SD 为 4.2/3.6mmHg(SBP/DBP)。这些结果满足医疗器械促进会/欧洲高血压学会/国际标准化组织通用标准(ISO 81060-2:2018)协议要求。
家庭血压测量的 Withings BPM Connect 示波设备满足医疗器械促进会/欧洲高血压学会/国际标准化组织通用标准(ISO 81060-2:2018)的所有准确性要求,因此可以推荐用于家庭血压测量。